BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Thermo Fisher Introduces Vulcan™ Automated Lab to Advance Semiconductor Process Development

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the launch of the Thermo...

March 19, 2025 | News

WuXi Biologics Introduces EffiX™ a High-Yield E. coli Expression Platform for Recombinant Proteins and Plasmid DNA Production

EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. ...

March 04, 2025 | News

Chime Biologics and Mabgeek Advance MG-K10 to U.S. Phase III Trials for Atopic Dermatitis and Asthma

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, announced its continued collaboration with Mabgeek ...

February 24, 2025 | News

LG Chem Begins Prototype Production of 100% Bio-Acrylic Acid in South Korea

LG Chem has launched prototype production of 100% bio-acrylic acid, which has received USDA Certified Biobased Product (BIOPREFERRED®) label. The pr...

February 13, 2025 | News

Wellumio’s Portable MRI ‘Axana’ Begins First Clinical Study in Australia for Rapid Stroke Detection

Wellumio, a New Zealand-based medical device company pioneering advancements in stroke detection, today announced enrollment of the first patien...

February 07, 2025 | News

Eleva and 3PBIOVIAN Forge Strategic Alliance to Advance Clinical-Grade Biologics Production

3PBIOVIAN provides production capacity for clinical-grade material for current and future development programs including Eleva’s proprietary Factor...

February 05, 2025 | News

Lyndra Partners with Thermo Fisher to Drive Phase 3 Trials and Commercial Manufacturing of Long-Acting Oral Therapies

Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra...

January 16, 2025 | News

ADELA Phase III Trial Combines Elacestrant and Everolimus to Tackle Advanced ER+/HER2- Breast Cancer with ESR1 Mutations

ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breas...

December 13, 2024 | News

CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...

December 13, 2024 | News

Hong Kong’s Viva Biotech Expands Global Footprint with Strategic Boston Branch Launch

Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston, USA. As a global leader in drug re...

December 12, 2024 | News

Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology

In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...

November 01, 2024 | Interview

Centivax Partners with Australia’s BioCina for cGMP Manufacturing of Universal Influenza Vaccine

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax...

October 10, 2024 | News

Synexa Life Sciences Acquires Alderley Analytical Ltd, Strengthening Bioanalytical Capabilities and Expanding European Reach

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near ...

October 08, 2024 | News

SK Bioscience Acquires IDT Biologika to Accelerate Global Growth and Dominate the CDMO Industry

- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in r...

October 02, 2024 | News

Stay Connected